1300. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has carried out any review of long-term patient outcomes associated with procedures funded under the treatment abroad scheme since 2020. [39202/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
27,342 questions match, newest first.
1301. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money framework exists comparing the clinical outcomes and costs associated with overseas procedures funded under the treatment abroad scheme against equivalent treatment pathways domestically. [39203/26]
1302. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any provider-level performance monitoring system in respect of overseas hospitals or clinics receiving treatment abroad scheme referrals. [39204/26]
1303. Deputy Ken O'Flynn asked the Minister for Health whether any formal patient safety governance framework exists specifically governing procedures funded under the treatment abroad scheme. [39205/26]
1304. Deputy Ken O'Flynn asked the Minister for Health the number of complaints, adverse incident reports, legal claims or clinical governance concerns associated with procedures funded under the treatment abroad scheme since 2020. [39206/26]
1305. Deputy Ken O'Flynn asked the Minister for Health whether the Department has sought legal advice regarding governance and duty-of-care obligations arising from State-funded overseas medical procedures where no structured outcomes monitoring system exists. [39207/26]
1306. Deputy Ken O'Flynn asked the Minister for Health whether the absence of structured clinical outcome monitoring under the treatment abroad scheme has been identified on any Departmental or HSE risk register. [39208/26]
1307. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains a category-specific expenditure breakdown for procedures funded under the treatment abroad scheme; and if so, whether gender affirmation surgeries are separately identifiable within those records. [39210/26]
1308. Deputy Ken O'Flynn asked the Minister for Health whether any value-for-money assessment has been conducted regarding overseas gender affirmation surgeries funded under the treatment abroad scheme since 2020. [39211/26]
1309. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment, governance review or assurance process has been undertaken specifically relating to overseas gender affirmation surgery approvals under the treatment abroad scheme. [39212/26]
1310. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has ever examined category-specific overseas treatment expenditure under the treatment abroad scheme; and if so, to provide details. [39213/26]
1311. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health receives specialty-specific approval or expenditure data from the treatment abroad scheme during quarterly oversight meetings. [39214/26]
1312. Deputy Ken O'Flynn asked the Minister for Health whether any national clinical governance framework exists governing referrals for overseas gender affirmation surgeries funded through the treatment abroad scheme. [39215/26]
1313. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the total annual number of gender affirmation surgery applications approved under the treatment abroad scheme since 2020, by year. [39216/26]
1314. Deputy Ken O'Flynn asked the Minister for Health whether any post-treatment outcome monitoring or follow-up governance arrangements exist for persons funded for overseas gender affirmation surgeries under the treatment abroad scheme. [39217/26]
1315. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has undertaken any national capacity assessment of the public pre-exposure prophylaxis (PrEP) programme since 2024; and if so, if she will provide details of the findings, including identified service gaps, unmet demand, regional pressures and recommended expansion measures. [39272/26]
1316. Deputy Ken O'Flynn asked the Minister for Health the number of persons currently awaiting access to public PrEP services, by clinic and by HSE health region; and whether this figure includes informal, paused or closed waiting lists. [39273/26]
1317. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any centralised record of persons unable to access public PrEP services due to capacity constraints; and if not, whether she considers the absence of such data to represent a governance or public health oversight issue. [39274/26]
1318. Deputy Ken O'Flynn asked the Minister for Health whether any risk assessment has been undertaken regarding individuals sourcing PrEP medication privately from overseas due to inability to access the public system; and if she will provide details of any such assessment. [39275/26]
1319. Deputy Ken O'Flynn asked the Minister for Health whether the absence of a national waiting list or central referral pathway for PrEP has been formally identified within the HSE or Department of Health as a patient safety, governance or access risk. [39276/26]
1320. Deputy Ken O'Flynn asked the Minister for Health whether any service-level target exists regarding maximum waiting times for access to public PrEP services; and if so, what compliance levels have been achieved during 2025 and 2026 to date. [39277/26]
1321. Deputy Ken O'Flynn asked the Minister for Health how many public PrEP clinics nationally are currently closed, fully or partially, to new self-referrals; the duration of each restriction; and the reasons cited for same. [39278/26]
1322. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has considered establishing a temporary national bridging pathway or interim prescribing arrangement for persons unable to access public PrEP services due to capacity limitations. [39279/26]
1323. Deputy Ken O'Flynn asked the Minister for Health the number of approved private or GP PrEP providers currently operating nationally and by county; and whether the HSE has assessed the financial impact on patients required to access private consultations and testing due to lack of public capacity. [39280/26]
1324. Deputy Ken O'Flynn asked the Minister for Health whether additional funding, staffing or clinic capacity has been allocated in 2026 to expand access to public PrEP services; and if she will provide a breakdown of same by region and service. [39281/26]